Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.47 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.43 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.43 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.43 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.43 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.43 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31235494 | 0.98 | KMT2A (0.46) | KMT2APAX8HSD11B1ALDH1A1CA2 | |
| SCHEMBL18225990 | 0.88 | ALDH1A1 (0.48) | KMT2APAX8HSD11B1ALDH1A1CA2 | |
| SCHEMBL15013716 | 0.82 | ALDH1A1 (0.56) | KMT2APAX8HSD11B1ALDH1A1CA2 | |
| SCHEMBL10702964 | 0.80 | GAA (0.59) | KMT2AALDH1A1CA2CYP3A4CYP2C9 | |
| SCHEMBL7033085 | 0.78 | CA2 (0.64) | KMT2APAX8HSD11B1ALDH1A1CA2 | |
| SCHEMBL1148799 | 0.78 | KMT2A (0.47) | KMT2APAX8HSD11B1ALDH1A1CA2 | |
| SCHEMBL1939594 | 0.78 | NPC1 (0.55) | KMT2AHSD11B1ALDH1A1CA2PSEN1 | |
| SCHEMBL13586189 | 0.78 | PLCG1 (0.61) | KMT2AHSD11B1ALDH1A1CA2F2 | |
| SCHEMBL1368369 | 0.78 | L3MBTL1 (0.53) | KMT2APAX8HSD11B1ALDH1A1CA2 | |
| SCHEMBL6752574 | 0.78 | CA2 (0.59) | KMT2APAX8ALDH1A1CA2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114551793-B | Lithium-based composite negative plate with long cycle life, preparation method thereof and solid lithium battery | 万向一二三股份公司 | 2023-10-03 | — | — | CN | claimed |
| CN-114551793-A | Lithium-based composite negative plate with long cycle life, preparation method thereof and solid lithium battery | 万向一二三股份公司 | 2022-05-27 | — | — | CN | claimed |
| CN-114551793-B | Lithium-based composite negative plate with long cycle life, preparation method thereof and solid lithium battery | 万向一二三股份公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-114551793-A | Lithium-based composite negative plate with long cycle life, preparation method thereof and solid lithium battery | 万向一二三股份公司 | 2022-05-27 | — | — | CN | disclosed |
| US-20220017516-A1 | LOX INHIBITORS | THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) | 2022-01-20 | — | — | US | disclosed |
| WO-2020231713-A1 | AGONISTS OF ROR GAMMAt | BRISTOL-MYERS SQUIBB COMPANY (US) | 2020-11-19 | — | — | WO | disclosed |
| WO-2020099886-A1 | LOX INHIBITORS | THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) | 2020-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220017516-A1 | LOX INHIBITORS | LOXL1, LOX, LOXL2 | KMT2A 2212/4885PAX8 4652/4885HSD11B1 897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.